Skip to main content
SpringerLink
Log in

The Significance of Hormone Routes of Administration

  • Chapter
  • First Online:
Hormone Therapy

Abstract

Oral administration has been the most popular form of HT, until the findings of the Women’s Health Initiative in 2002. At times, in the form of Premarin, oral HT has been among the top-prescribed drugs in the United States.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Bäckström T, Haage D, Löfgren M, et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience. 2011;191:46–54.

    Article  PubMed  Google Scholar 

  2. Cagnacci A, De Toni A, Caretto S, et al. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause. 2006;13(2):197–201.

    Article  PubMed  Google Scholar 

  3. Caufriez A, Leproult R, L’Hermite-Balériaux M, et al. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab. 2011;96(4):E614–23.

    Article  PubMed  CAS  Google Scholar 

  4. Cavallini A, Dinaro E, Giocolano A, et al. Estrogen receptor (ER) and ER-related receptor expression in normal and atrophic human vagina. Maturitas. 2008;59: 219–25.

    Article  PubMed  CAS  Google Scholar 

  5. Cummings JA, Brizendine L. Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women. Menopause. 2002;9(4):253–63.

    Article  PubMed  Google Scholar 

  6. Dayspring T, Pokrywka G. Pharmacotherapeutic decisions in menopausal women with cardiovascular risk. Future Lipidol. 2007;2(2):197–210.

    Article  CAS  Google Scholar 

  7. Empson JAC, Purdie DW. Effects of sex steroids on sleep. Ann Med. 1999;31:141–5.

    PubMed  CAS  Google Scholar 

  8. Hachul H, Bittencourt LRA, Andersen ML, et al. Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet. 2008;103:207–12.

    Article  PubMed  CAS  Google Scholar 

  9. Laliberté F, Dea K, Sheng Duh M, et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause. 2011;18(10): 1052–9.

    Article  PubMed  Google Scholar 

  10. Krychman ML. Vaginal estrogens for the treatment of dyspareunia [review]. J Sex Med. 2011;8:666–74.

    Article  PubMed  Google Scholar 

  11. North American Menopause Society. Hormone products for postmenopausal use in the United States and Canada. Mayfield Heights, OH: North American Menopause Society; 2011.

    Google Scholar 

  12. Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011;30(5):754–7.

    Article  PubMed  CAS  Google Scholar 

  13. Shoupe D. Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits. Womens Health (Lond Engl). 2011;7(4):475–85.

    Article  CAS  Google Scholar 

  14. Shufelt CL, Delia Johnson B, Berga SL, et al. Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation. Menopause. 2011;18(9):943–50.

    Article  PubMed  Google Scholar 

  15. Skouby SO, Jespersen J. Progestins in HRT: sufferance or desire? [review]. Maturitas. 2009;62:371–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drexel Center for Women’s Health, Drexel University College of Medicine, Philadelphia, PA, USA

    Katherine Sherif MD, FACP

Authors
  1. Katherine Sherif MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). The Significance of Hormone Routes of Administration. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation